v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenue $ 1,533 $ 1,481
Operating expenses    
Research and development 11,255 9,529
General and administrative 8,117 6,453
Total operating expenses 19,372 15,982
Loss from operations (17,839) (14,501)
Interest income 132 343
Interest expense (1,320) (1,257)
Other (expense) income, net (150) 65
Total other (expense) income (1,338) (849)
Net loss (19,177) (15,350)
Other comprehensive income (loss)    
Foreign currency translation adjustment (103) (8)
Comprehensive loss (19,280) (15,358)
Net loss attributable to shareholders - basic (19,177) (15,350)
Net loss attributable to shareholders - diluted $ (19,177) $ (15,350)
Weighted shares used in calculating net loss per common share - basic (in shares) 327,543,855 291,996,562
Weighted shares used in calculating net loss per common share - diluted (in shares) 327,543,855 291,996,562
Net loss per share attributable to shareholders - basic (in USD per share) $ (0.06) $ (0.05)
Net loss per share attributable to shareholders - diluted (in USD per share) $ (0.06) $ (0.05)
Collaborative Arrangements    
Total revenue $ 1,533 $ 1,481
Operating expenses    
Research and development $ 800 $ 800